Research indicates that this endotoxemia-driven inflammation can cross the blood-brain barrier, activating microglial cells in the brain and driving the severe neuroinflammation, brain fog, and profound fatigue seen in both Long COVID and ME/CFS
[PMID: 6178854] PubMed record related to this compound for laboratory literature review
27 In CY-5 experiments, replacing Arg 18 from GCG with Ala simultaneously improved both the GLP-1 and GIP activity
in In nov ative M ed icine : Basic Research and Developmen t (eds
These results, allied to recent meta-analyses from limited clinical trial data, underscore the need for a dedicated cardiorenal outcome trial to obtain direct evidence for the (cardiorenal) benefits and risks of SGLT2 inhibitor and GLP-1 RA combination therapy
doi: 10.1016/j.biopsych.2026.05.002 10.1016/j.biopsych.2026.05.002